Similarly, Sui et al. demonstrated that in lung adenocarcinoma, TAM-secreted S100A9 enhances tumor cell survival and resistance to current therapies by modulating inflammation and immune responses [28]. This evidence concerns the gene S100A9 and lung adenocarcinoma.